With the latest funding round, Blood Cancer United's cumulative research funding tops $2 billion, continuing to help increase survival rates and improve patients' lives

Blood Cancer United's new research funding supports foundational science, AI, big data and global collaborations to improve patient outcomes

WASHINGTON , Dec. 2, 2025 /PRNewswire/ -- Blood Cancer United®, formerly The Leukemia & Lymphoma Society, announced today new scientific grants and investments to continue momentum toward cures and a better quality of life for all people with blood cancer and their families.

"Ongoing research funding from patient-minded groups like Blood Cancer United is more critical than ever," says E. Anders Kolb, M.D., Blood Cancer United President and CEO. "Our federal research infrastructur

See Full Page